Ceftazidime therapy versus aminoglycoside therapy in patients with gram-negative burn wound infections.
D000328:Adult; D002056:Burns / Q000150:complications*; D002442:Ceftazidime / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D014031:Tobramycin / Q000627:therapeutic use*; D014946:Wound Infection / Q000188:drug therapy* / Q000382:microbiology
D002442:Ceftazidime; D014031:Tobramycin